Wealth Enhancement Advisory Services LLC Buys 1,900 Shares of Chemed Corporation $CHE

Wealth Enhancement Advisory Services LLC grew its stake in Chemed Corporation (NYSE:CHE) by 79.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,289 shares of the company’s stock after purchasing an additional 1,900 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Chemed were worth $1,871,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Geneos Wealth Management Inc. increased its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the last quarter. Lecap Asset Management Ltd. bought a new position in Chemed during the 2nd quarter valued at about $978,000. DAVENPORT & Co LLC raised its position in Chemed by 10.2% in the 2nd quarter. DAVENPORT & Co LLC now owns 474 shares of the company’s stock worth $231,000 after purchasing an additional 44 shares during the period. KLP Kapitalforvaltning AS raised its position in Chemed by 26.3% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 4,800 shares of the company’s stock worth $2,337,000 after purchasing an additional 1,000 shares during the period. Finally, Roundview Capital LLC lifted its stake in Chemed by 2.4% in the second quarter. Roundview Capital LLC now owns 2,072 shares of the company’s stock worth $1,009,000 after purchasing an additional 48 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Down 0.7%

Shares of CHE stock opened at $427.00 on Friday. The firm has a market cap of $6.05 billion, a price-to-earnings ratio of 22.58, a PEG ratio of 2.09 and a beta of 0.44. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The company’s 50 day moving average is $436.55 and its 200 day moving average is $442.46.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.39 by ($0.12). The company had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The firm’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the business posted $5.64 EPS. Analysts anticipate that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio is presently 12.69%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.29% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CHE. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Finally, Royal Bank Of Canada reduced their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Chemed has an average rating of “Moderate Buy” and an average target price of $555.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.